[1]
Mirhadi, E.; Mashreghi, M.; Faal Maleki, M.; Alavizadeh, S.H.; Arabi, L.; Badiee, A.; Jaafari, M.R. Redox-sensitive nanoscale drug delivery systems for cancer treatment. Int. J. Pharm., 2020, 589, 119882.
[http://dx.doi.org/10.1016/j.ijpharm.2020.119882] [PMID: 32941986]
[http://dx.doi.org/10.1016/j.ijpharm.2020.119882] [PMID: 32941986]
[2]
Kim, K.S.; Lee, D.; Song, C.G.; Kang, P.M. Reactive oxygen species-activated nanomaterials as theranostic agents. Nanomedicine (Lond.), 2015, 10(17), 2709-2723.
[http://dx.doi.org/10.2217/nnm.15.108] [PMID: 26328770]
[http://dx.doi.org/10.2217/nnm.15.108] [PMID: 26328770]
[3]
Tao, W.; He, Z. ROS-responsive drug delivery systems for biomedical applications. Asian J. Pharm. Sci., 2018, 13(2), 101-112.
[4]
Liang, J.; Liu, B. ROS-responsive drug delivery systems. Bioeng. Transl. Med., 2016, 1(3), 239-251.
[http://dx.doi.org/10.1002/btm2.10014] [PMID: 29313015]
[http://dx.doi.org/10.1002/btm2.10014] [PMID: 29313015]
[5]
Liu, J.; Li, Y.; Chen, S.; Lin, Y.; Lai, H.; Chen, B.; Chen, T. Biomedical application of reactive oxygen species–responsive nanocarriers in cancer, inflammation, and neurodegenerative diseases. Front Chem., 2020, 8, 838.
[http://dx.doi.org/10.3389/fchem.2020.00838] [PMID: 33062637]
[http://dx.doi.org/10.3389/fchem.2020.00838] [PMID: 33062637]
Related Journals
Current Pharmaceutical Design
Current Topics in Medicinal Chemistry
Current Respiratory Medicine Reviews
Infectious Disorders - Drug Targets
Endocrine, Metabolic & Immune Disorders - Drug Targets
Anti-Infective Agents
Coronaviruses
Recent Advances in Inflammation & Allergy Drug Discovery
Current Probiotics
Article Metrics
22
1